Chemohormone Therapy Prior to Prostatectomy in High Risk Prostate Cancer
Phase 2
18 Years
80 Years
18 Years
80 Years
Not Enrolling
Male
Prostate Cancer
Male
Prostate Cancer
Trial Information
Chemohormone Therapy Prior to Prostatectomy in High Risk Prostate Cancer
Inclusion Criteria:
- High risk prostate cancer without evidence of bone metastasis.
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Authority:
United States: Federal Government
Study ID:
CLIN-003-02F
NCT ID:
NCT00108290
Start Date:
April 2004
Completion Date:
March 2007
Related Keywords:
- Prostate Cancer
- Prostate cancer
- chemotherapy
- hormone therapy
- surgery
- PSA
- Gleason score
- Prostatic Neoplasms
Name | Location |
|---|---|
| VA Maryland Health Care System | Baltimore, Maryland 21201 |
